Our bioinformatics analysis of The Cancer Genome Atlas (TCGA) dataset and histological analysis of over 100 patient tissues confirmed LSR overexpression in most TNBCs and ER+/PR+/HER2+ breast cancers. This evidence concerns the gene ERBB2 and breast carcinoma.